The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a https://blakejzou679300.timeblog.net/74552059/retatrutide-vs-tirzepatide-a-comparative-analysis